George Green

George Green

Company: Bristol Myers Squibb

Job title: Executive Director, Head of Pharmacodiagnostic Sciences


George A. Green IV, PhD is Executive Director and Head of Pharmacodiagnostic Sciences in the Bristol Myers Squibb Translational Medicine organization.  Joining BMS in March 2010 as the company’s first subject matter expert in diagnostic development, Dr. Green played a key role in establishing Pharmacodiagnostics as a core capability within the company and for BMS as an industry leader in the field.  As Head of the Pharmacodiagnostics team & matrix organization, he is responsible for providing the BMS enterprise capability for the development and delivery of diagnostic products that support Precision Medicine therapeutic assets. Under his leadership, the Pharmacodiagnostics team drives development strategy through support of early decision-making in signal seeking clinical development through robust & effective patient selection hypothesis testing; and supports the development & commercial success of BMS assets through delivery of Companion and Complementary Diagnostic products in support of the clinical validation & registration of Precision Medicine assets. Dr. Green’s experience in development programs includes oncology, neuroscience, cardiovascular, and virology, as well as early diagnostic development programs across multiple therapeutic areas and technology platforms.  Dr. Green received his PhD degree in Microbiology from The Ohio State University and holds a BA degree from University of Pennsylvania.


© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.